# Veraxa (VRXA) — News

VRXA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vrxa/news

## Recent headlines

- [Veraxa Biotech appoints Raju Willener as chief financial officer](https://www.ainvest.com/news/veraxa-biotech-appoints-raju-willener-chief-financial-officer-2609) — AInvest Wire, Sep 4, 2026
  Veraxa Biotech AG has announced the appointment of Raju Willener as its new Chief Financial Officer (CFO), succeeding Carl von Halem, who will transition to a different role within the company. The appointment follows the recent shareholder approvals of the merger between Veraxa and Veraxa Biotech…
- [Veraxa Biotech Holding AG - files to register resale of up to 25 mln ordinary shares - SEC filing](https://www.ainvest.com/news/veraxa-biotech-holding-ag-files-register-resale-25-mln-ordinary-shares-sec-filing-2608) — AInvest Wire, Jul 31, 2026
  Veraxa Biotech Holding AG has filed with the U.S. Securities and Exchange Commission (SEC) to register the resale of up to 25 million ordinary shares, according to a recent SEC filing. The registration is part of a broader capital-raising initiative by the company, which is in the process of…
- [Veraxa Biotech shareholders approve all proposals at extraordinary general meeting, strengthening strategic flexibility for future growth](https://www.ainvest.com/news/veraxa-biotech-shareholders-approve-proposals-extraordinary-general-meeting-strengthening-strategic-flexibility-future-growth-2607) — AInvest Wire, Jul 24, 2026
  Veraxa Biotech shareholders approved all proposals presented at an extraordinary general meeting held recently, granting the company enhanced strategic flexibility to pursue future growth opportunities. The proposals included adjustments to the company’s share authorization and modifications to its…
- [Veraxa Biotech names Carl von Halem as interim CFO](https://www.ainvest.com/news/veraxa-biotech-names-carl-von-halem-interim-cfo-2607) — AInvest Wire, Jul 10, 2026
- [Veraxa Biotech AG appoints Carl von Halem as interim chief financial officer and successor to Torsten Bürgermeister](https://www.ainvest.com/news/veraxa-biotech-ag-appoints-carl-von-halem-interim-chief-financial-officer-successor-torsten-rgermeister-2607) — AInvest Wire, Jul 10, 2026
  Veraxa Biotech AG has announced the appointment of Carl von Halem as interim Chief Financial Officer (CFO), succeeding Torsten Bürgermeister. The transition follows Bürgermeister’s decision to step down from his role, though the company has not disclosed the specific reasons for the change. Von…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).